Numbers didn't add up for Maitec

Knowing when to quit is as important as knowing when to forge ahead. The Liposome Co. Inc., which has a full plate of development projects, last week said it suspended development of Maitec, its liposomal gentamicin product, after looking at the economics of the drug. LIPO now plans to seek